Skip to content

Comparison of the effects of two administration modes of dexmedetomidine nasal spray in monitoring anesthesia during foraminoscopy

Comparison of the effects of two administration modes of dexmedetomidine nasal spray in monitoring anesthesia during foraminoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097272
Enrollment
Unknown
Registered
2025-02-17
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

protrusion of lumbar intervertebral disc

Interventions

Sitting nasal spray group:Dexmedetomidine nasal spray was administered through the nose while seated
Prone position nasal spray group:Dexmedetomidine nasal spray was administered in a prone position
Buccal mucosa administration group in prone position:Dexmedetomidine nasal spray 100ug was administered via buccal mucosa in prone position

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing foraminoscopy under anesthesia in Hebei Provincial People's Hospital were male and female, aged 18-65 years old, with clear consciousness and capacity for civil conduct, and no contraindications to surgery and anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with severe rhinitis and nasal malformations; Patients with mouth ulcers. 2. Patients with myocardial infarction, unstable angina pectoris, severe arrhythmia, and cardiac insufficiency. 3. Patients with severe asthma, severe emphysema, severe bronchitis, and severe chronic obstructive pulmonary disease. 4. Patients with severe liver insufficiency. 5. Patients allergic to dexmedetomidine and its ingredients 6. Patients refuse. 7. Patients with serious adverse reactions occurred during the operation, terminating the operation or changing the anesthesia method.

Design outcomes

Primary

MeasureTime frame
The depth of anesthesia and sedation;Modified Observational Assessment of Alertness and Sedation, MOAA/S;Ramsay;visual analogue scale;heart rate variability;

Secondary

MeasureTime frame
blood pressure;heart rate;saturation of pulse oximetry;perfusion index;adverse reaction;

Countries

China

Contacts

Public ContactZhang Dong

Hebei General Hospital

zhangdongdoctor@126.com+86 311 85988127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026